Cargando…

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2

PURPOSE OF REVIEW: The intestine is highly efficient at absorbing and packaging dietary lipids onto the structural protein apoB48 for distribution throughout the body. Here, we summarize recent advances into understanding the physiological and pharmacological actions of the proglucagon-derived pepti...

Descripción completa

Detalles Bibliográficos
Autor principal:	Mulvihill, Erin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	GENETICS AND MOLECULAR BIOLOGY: Edited by Robert A. Hegele
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882252/ https://www.ncbi.nlm.nih.gov/pubmed/29432213 http://dx.doi.org/10.1097/MOL.0000000000000495

Ejemplares similares

Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
por: Holst, Jens Juul
Publicado: (2022)

Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
por: Clarke, Shoa L.
Publicado: (2023)

DNA methylation in human lipid metabolism and related diseases
por: Mittelstraß, Kirstin, et al.
Publicado: (2018)

Progress in genetic association studies of plasma lipids
por: Asselbergs, Folkert W., et al.
Publicado: (2013)

The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case
por: Wand, Hannah, et al.
Publicado: (2021)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women
por: Montes Castillo, María Cristina, et al.
Publicado: (2019)

Blockade of glucagon increases muscle mass and alters fiber type composition in mice deficient in proglucagon‐derived peptides
por: Ueno, Shinji, et al.
Publicado: (2023)

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence
por: Sherratt, Samuel C.R., et al.
Publicado: (2020)

The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
por: Cupido, Arjen J., et al.
Publicado: (2021)

CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
por: Glatz, Jan F.C., et al.
Publicado: (2022)

Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia
por: Hang, Shyann M.T., et al.
Publicado: (2023)

Acylation of Glucagon-Like Peptide-2: Interaction with Lipid Membranes and In Vitro Intestinal Permeability
por: Trier, Sofie, et al.
Publicado: (2014)

Editorial: Proglucagon-Derived Peptides
por: Flatt, Peter R., et al.
Publicado: (2021)

Proglucagon-Derived Peptides as Therapeutics
por: Lafferty, Ryan A., et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Gene Therapy
por: Rowzee, Anne M., et al.
Publicado: (2011)

Glucagon-Like Peptide-1 and Diabetes 2012
por: Monami, Matteo, et al.
Publicado: (2012)

Glucagon-like peptide-1 analogues: An overview
por: Gupta, Vishal
Publicado: (2013)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Chicken Intestinal L Cells and Glucagon-like Peptide-1 Secretion
por: Hiramatsu, Kohzy
Publicado: (2020)

Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport
por: Lee, Jennifer, et al.
Publicado: (2017)

Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles
por: Bueno, Ana B., et al.
Publicado: (2016)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Direct cardiovascular effects of glucagon like peptide-1
por: Sheikh, Asfandyar
Publicado: (2013)

Is ghrelin a glucagon‐like peptide‐1 secretagogue?
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Equine glucagon-like peptide-1 receptor physiology
por: Kheder, Murad H., et al.
Publicado: (2018)

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
por: Paternoster, Silvano, et al.
Publicado: (2018)

Levels of glucagon-like peptide 1 in hyperemesis gravidarum
por: Aktulay, Ayla, et al.
Publicado: (2021)

Mutational Landscape of the Proglucagon-Derived Peptides
por: Lindquist, Peter, et al.
Publicado: (2021)

Glucagon‐like peptide‐1: The missing link in the metabolic clock?
por: Brubaker, Patricia L, et al.
Publicado: (2016)

Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals
por: Irwin, David M.
Publicado: (2021)

The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an “Endothelial Resistance” to Glucagon-Like Peptide 1 in Diabetes
por: Ceriello, Antonio, et al.
Publicado: (2011)

Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats
por: Wu, Jiayu, et al.
Publicado: (2018)

Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
por: Rogers, G J, et al.
Publicado: (2011)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
por: Murakami, Takaaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hsru27duh1l13bj6rmegdvk7h6